Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric validation study of intranasal dexmedetomidine extrapolated from adult data
ChiCTR2400081244Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children’s Medical Center
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in vascular malformation and lymphangioma (3 arms), sponsored by Guangzhou Women and Children’s Medical Center. Primary endpoint: Pharmacokinetic parameters. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
vascular malformationlymphangioma
Beyond the preview
Go deeper on ChiCTR2400081244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081244.